Jeff EltonCEO of Concerto HealthAi
Jeff Elton, Ph.D., is CEO of Concerto HealthAI, a rapidly growing Precision Oncology company with facilities in New York, Philadelphia, Los Altos, and Bangalore that recently moved its headquarters to Boston. Concerto HealthAI is a partner with the American Society of Clinical Oncology’s CancerLinQ program, working with that group and U.S. FDA to advance the use of real world data for pre- and post-approval regulatory submissions, outcomes studies, and value-based care. Previously, he was Managing Director, Accenture Strategy & Predictive Health Intelligence, global COO of Novartis’ Institutes for BioMedical Research and a McKinsey partner in Pharmaceuticals & Medical Products. Dr. Elton co-authored, “Healthcare Disrupted: Next Generation Business Models and Strategies” in 2016, creating an industry roadmap for AI, advanced analytics, real-world data and digital medical solutions.